Factors Determining Responses to Azacitidine in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Early Post-Transplantation Relapse: A Prospective Trial.
Biol Blood Marrow Transplant
; 23(1): 176-179, 2017 01.
Article
in En
| MEDLINE
| ID: mdl-27789363
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Azacitidine
/
Myelodysplastic Syndromes
/
Remission Induction
/
Leukemia, Myeloid, Acute
/
Hematopoietic Stem Cell Transplantation
/
Induction Chemotherapy
Type of study:
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2017
Type:
Article